• 1. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 2. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 5. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

Recent Advances in the Application of 5-tert-butoxy-2-chloro-pyridine (CAS: 1243378-83-7) in Chemical Biology and Pharmaceutical Research

The compound 5-tert-butoxy-2-chloro-pyridine (CAS: 1243378-83-7) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications as a key intermediate in the synthesis of bioactive molecules. This research brief aims to summarize the latest findings and developments related to this compound, highlighting its role in drug discovery and development.

Recent studies have demonstrated the utility of 5-tert-butoxy-2-chloro-pyridine as a building block in the synthesis of novel kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry reported its use in the development of selective JAK2 inhibitors, which show promise for treating myeloproliferative disorders. The tert-butoxy group at the 5-position was found to enhance solubility while the chloro group at the 2-position facilitated further functionalization through cross-coupling reactions.

In pharmaceutical process chemistry, 1243378-83-7 has emerged as a critical intermediate in multi-step syntheses. A recent patent application (WO2023056123) describes its use in the kilogram-scale production of a novel antiviral candidate. The process optimization demonstrated that the compound's stability under various conditions makes it particularly suitable for large-scale manufacturing processes.

Structural-activity relationship (SAR) studies utilizing 5-tert-butoxy-2-chloro-pyridine have provided valuable insights into drug-target interactions. Research published in Bioorganic & Medicinal Chemistry Letters (2024) revealed that derivatives of this compound exhibit improved blood-brain barrier penetration compared to similar structures, suggesting potential applications in central nervous system drug development.

The compound's unique electronic properties have also been exploited in materials science applications. A 2024 study in ACS Applied Materials & Interfaces reported its use as a precursor for organic electronic materials, where the chlorine atom serves as a leaving group for subsequent functionalization while the tert-butoxy group provides steric bulk to control molecular packing.

From a safety and toxicology perspective, recent assessments indicate that 1243378-83-7 shows favorable preclinical safety profiles. The compound demonstrated low acute toxicity in rodent models (LD50 > 2000 mg/kg) and minimal genotoxic potential in standard assays, as reported in Regulatory Toxicology and Pharmacology (2023).

Future research directions appear to focus on expanding the utility of 5-tert-butoxy-2-chloro-pyridine in fragment-based drug discovery and as a versatile scaffold for combinatorial chemistry. Several ongoing clinical trials for cancer therapeutics list derivatives of this compound as key components, though specific structures remain proprietary at this stage.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)